Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease

Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, Chincarini A, Cagnin A, De Deyn PP, Düzel E, Engelborghs S, Ewers M, Exalto LG, van der Flier WM, Fortea J, Frederiksen KS, Frisoni GB, Frölich L, Garza-Martinez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Kehoe PG, Kennelly SP, Kern S, Klöppel S, Krajčovičová L, Kramberger MG, McGuinness B, Mecocci P, Oberstein T, Ousset PJ, Paquet C, Perneczky R, Piazza F, Plantone D, Rainero I, Sacco G, Salmon E, Santana I, Scarmeas N, Schneider A, Schott JM, Solje E, Stefanova E, Stögmann E, Strauss M, Sutovsky S, Waldemar G, Winblad B (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Book Volume: 12

Pages Range: 100259-

Journal Issue: 8

DOI: 10.1016/j.tjpad.2025.100259

Authors with CRIS profile

Involved external institutions

University Medical Centre Utrecht (UMC Utrecht) Netherlands (NL) Vrije Universiteit Amsterdam (VU) / University Amsterdam Netherlands (NL) Autonomous University of Barcelona (UAB) / Universitat Autònoma de Barcelona Spain (ES) Rigshospitalet Denmark (DK) Geneva University Hospitals / Hôpitaux universitaires de Genève (HUG) Switzerland (CH) Universitätsklinikum Mannheim Germany (DE) Hospital Universitario Ramón y Cajal Spain (ES) Technische Universität München (TUM) Germany (DE) Cliniques universitaires Saint-Luc (CHU St-Luc) Belgium (BE) Motol University Hospital / Fakultní nemocnice v Motole Czech Republic (CZ) University of Bristol United Kingdom (GB) Tallaght University Hospital Ireland (IE) Sahlgrenska University Hospital / Sahlgrenska Universitetssjukhuset Sweden (SE) Universität Bern Switzerland (CH) St. Anne's University Hospital / Sv. Anny v Brně Czech Republic (CZ) Ljubljana University Medical Centre (Ljubljana UMC) / Univerzitetni klinični center Ljubljana Slovenia (SI) Queen's University United Kingdom (GB) Università degli Studi di Perugia Italy (IT) Centre Hospitalier Universitaire (CHU) de Toulouse France (FR) University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB Italy (IT) University of Turin / Università degli Studi di Torino (UNITO) Italy (IT) University of Côte d'Azur / Université Côte d'Azur France (FR) Centre Hospitalier Universitaire de Liège (CHU Liège) Belgium (BE) Universidade de Coimbra Portugal (PT) Universitätsklinikum Bonn Germany (DE) University College London (UCL) United Kingdom (GB) University of Eastern Finland Finland (FI) University of Belgrade / Универзитет у Београду Serbia (RS) Medizinische Universität Wien Austria (AT) Hôpital Erasme Belgium (BE) Comenius University Bratislava Slovakia (SK) Karolinska University Hospital / Karolinska Universitetssjukhuset Sweden (SE) Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP) France (FR) Zagreb University Hospital Centre / Klinički bolnički centar Zagreb (KBC) Croatia (HR) Klinikum der Universität München Germany (DE) National Institute for Nuclear Physics / Istituto Nazionale di Fisica Nucleare (INFN) Italy (IT) University of Padua / Universita degli Studi di Padova Italy (IT) University of Antwerp / Universiteit Antwerpen Belgium (BE) Otto-von-Guericke-Universität Magdeburg Germany (DE) Universitair Ziekenhuis Brussel Belgium (BE) Navarre Institute of Health Research / Instituto de Investigación Sanitaria de Navarra (IdisNa) Spain (ES) Universitat Internacional de Catalunya Spain (ES) Hospital Clínic de Barcelona Spain (ES) Université Sorbonne Paris Cité France (FR) Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Germany (DE)

How to cite

APA:

Jessen, F., Arbizu, J., Boada, M., Balasa, M., Bennys, K., Boban, M.,... Winblad, B. (2025). Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease. The Journal of Prevention of Alzheimer's Disease, 12(8), 100259-. https://doi.org/10.1016/j.tjpad.2025.100259

MLA:

Jessen, Frank, et al. "Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease." The Journal of Prevention of Alzheimer's Disease 12.8 (2025): 100259-.

BibTeX: Download